FORMER CEO: Alex Gorsky served as Chairman & CEO of Johnson & Johnson from 2012 to 2022. He transitioned to Executive Chairman in January 2022 and retired in January 2023. The current Chairman & CEO of Johnson & Johnson is Joaquin Duato, who assumed the role in January 2022.
Johnson & Johnson, one of the world’s largest and most diversified healthcare companies, was led by Alex Gorsky as Chairman and Chief Executive Officer from 2012 to 2022. A decorated U.S. Army veteran and West Point graduate, Gorsky spent the majority of his career at Johnson & Johnson, rising from a sales representative at Janssen Pharmaceutica in 1988 to the top leadership position. Under his decade-long tenure, J&J grew from roughly $67 billion to over $93 billion in annual revenue, navigated complex challenges including the opioid litigation crisis and the COVID-19 pandemic, and developed one of the world’s first single-dose COVID-19 vaccines. Today, Gorsky remains influential as a board director at Apple, IBM, and JPMorgan Chase, and as a General Partner at ICONIQ Capital.
(Suggested: Pfizer CEO Email & Net Worth – Albert Bourla Salary)

Alex Gorsky – Quick Facts
Johnson & Johnson Competitors
Johnson & Johnson competes across multiple healthcare sectors including pharmaceuticals, medical devices, and consumer health. The key competitors of Johnson & Johnson include:
- Pfizer – global pharmaceutical giant competing in vaccines, oncology, and immunology
- AbbVie – major biopharmaceutical company (Humira, Skyrizi, Rinvoq)
- Roche – Swiss pharma and diagnostics leader (Genentech subsidiary)
- Eli Lilly – global pharma with leading diabetes and oncology portfolios
- Merck & Co. – pharma competitor in oncology (Keytruda) and vaccines
- Novartis – Swiss pharmaceutical multinational across multiple therapeutic areas
- AstraZeneca – biopharmaceutical company in oncology, cardiovascular, and respiratory
- Medtronic – global leader in medical devices and technologies
Alex Gorsky Net Worth 2026 – Johnson & Johnson CEO Salary
As of 2026, Alex Gorsky’s net worth is estimated at approximately $200–240 million USD. This estimate reflects his extensive stock holdings accumulated over a decade as CEO, plus board compensation from Apple, IBM, and JPMorgan Chase, and his role as General Partner at ICONIQ Capital. During his tenure, Gorsky earned over $162 million in total disclosed compensation from Johnson & Johnson alone.
Alex Gorsky – J&J CEO Compensation Breakdown (FY2021, Final Full Year as CEO)
Johnson & Johnson Net Worth 2026 – Is J&J Profitable?
Yes, Johnson & Johnson is one of the most profitable companies in the world. Under current CEO Joaquin Duato, the company has continued the growth trajectory built during Alex Gorsky’s tenure, reaching nearly $94.2 billion in revenue for full-year 2025 and a market capitalization approaching $600 billion.
Johnson & Johnson Financial Summary (FY2025)
(Recommended: AbbVie CEO Email & Net Worth – Richard Gonzalez Salary)
Alex Gorsky Contact – Email Address & Social Media
Below are the available contact details and social media profiles for former Johnson & Johnson CEO Alex Gorsky:
Career & Education – Company, University, & College
Alex Gorsky’s career spans over three decades in the pharmaceutical and healthcare industry, combined with distinguished military service. He is one of the longest-serving CEOs in Johnson & Johnson’s modern history, leading the company for a full decade. Below is his complete career timeline:
Alex Gorsky Career Timeline
Alex Gorsky began his Johnson & Johnson career as a sales representative with Janssen Pharmaceutica in 1988, shortly after completing his military service. Over the next 15 years, he advanced through positions of increasing responsibility in sales, marketing, and management across J&J’s pharmaceutical businesses. In 2001, he was appointed President of Janssen, and in 2003, he was promoted to Company Group Chairman for J&J’s pharmaceutical business in Europe, the Middle East, and Africa.
In 2004, Gorsky departed to join Novartis Pharmaceuticals Corporation as Chief Operating Officer and Head of General Medicines. He subsequently became Head of Pharma North America and CEO of Novartis Pharmaceuticals. However, in 2008, Gorsky returned to Johnson & Johnson as Company Group Chairman for Ethicon, the company’s surgical care division.
(Related: Novartis CEO Email & Net Worth – Vas Narasimhan Salary)
By 2009, he was appointed Worldwide Chairman of the Surgical Care Group and a member of the Executive Committee. In 2011, he became Vice Chairman of the Executive Committee, and in April 2012, he was named CEO of Johnson & Johnson, succeeding William C. Weldon. He added the Chairman title in December 2012. In January 2022, Gorsky transitioned to Executive Chairman, handing the CEO role to Joaquin Duato, and retired fully from J&J in January 2023.
Education

Alex Gorsky Wiki – Age, Wife, Family, & More
Alex Gorsky (age 65, born May 24, 1960) grew up in a close-knit family with his parents Albert and Loretta Gorsky and five siblings. After graduating from West Point in 1982, he served six years in the U.S. Army as an Army Ranger, achieving the rank of Captain before transitioning to the private sector.
In 1988, Gorsky married Patricia (Pat) Dittrich, a hospital nurse in Carmel, California. The couple have one son, Nick. Gorsky has long credited his wife and sister Therese, both nurses, as major influences in his understanding of the healthcare system. He and Pat have been generous philanthropists, donating $5 million to the Doylestown Health Foundation in 2017 and another $5 million in 2022.
Notable Achievements & Recognitions
- COVID-19 Vaccine Development – Led J&J’s development of the single-dose Janssen COVID-19 vaccine, one of the first authorized worldwide
- PharmaVoice “100 Most Inspiring Leaders” – Named in 2017 for his industry leadership
- Barron’s Most Admired Company – Under his leadership, J&J was ranked as the world’s most admired company (2016)
- Board Director at Apple, IBM, and JPMorgan Chase – Serves on three of the world’s most influential corporate boards
- IBM Lead Independent Director – Has served on IBM’s Board since 2014
- Veterans’ Advocate – Long-standing champion of veterans’ employment and inclusion initiatives
- Travis Manion Foundation Board Member – Supports veterans and families of fallen heroes
- Wharton School Board of Advisors – Active advisor at his MBA alma mater
Gorsky has long advocated for work-life balance and diversity in the workplace. He is known for saying that one of the most important lessons he learned early in life was to “be pleased but not satisfied” — a philosophy that drove his decade-long leadership of one of the world’s largest healthcare companies.
(Suggested: Merck CEO Email & Net Worth – Robert Davis Salary)
About Johnson & Johnson
Johnson & Johnson is an American multinational healthcare corporation headquartered in New Brunswick, New Jersey. Founded in 1886 by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson, the company is one of the oldest and most diversified healthcare enterprises in the world. Following the 2023 spin-off of its consumer health division as Kenvue, Johnson & Johnson now operates in two primary segments:
Johnson & Johnson trades on the New York Stock Exchange under the ticker symbol JNJ. With a market capitalization of approximately $599 billion as of early 2026, it is one of the most valuable healthcare companies in the world. The company employs over 130,000 people globally and has been a constituent of the Dow Jones Industrial Average since 1997.
Frequently Asked Questions (FAQ)
Who is the current CEO of Johnson & Johnson?
The current Chairman and CEO of Johnson & Johnson is Joaquin Duato, who assumed the CEO role in January 2022. Alex Gorsky served as Chairman & CEO from 2012 to 2022 before transitioning to Executive Chairman and then retiring in January 2023.
What is Alex Gorsky’s net worth in 2026?
As of 2026, Alex Gorsky’s net worth is estimated at approximately $200–240 million USD. This estimate is based on his accumulated J&J stock holdings from over a decade as CEO (he earned $162+ million in total disclosed compensation), combined with board fees from Apple, IBM, and JPMorgan Chase, and his investment role at ICONIQ Capital.
What was Alex Gorsky’s salary as J&J CEO?
Alex Gorsky’s total compensation for his final full year as CEO (fiscal year 2021) was approximately $26.7 million, including a $1.65 million base salary, $4.3 million annual bonus, $15 million in stock awards, and $5.1 million in option awards. Over 93% of his pay was performance-based.
What is Alex Gorsky’s email address?
Alex Gorsky’s email address at Johnson & Johnson was [email protected]. He can also be reached via his LinkedIn profile. For general J&J inquiries, contact the corporate headquarters at One Johnson & Johnson Plaza, New Brunswick, NJ 08933.
What does Alex Gorsky do now?
Since retiring from Johnson & Johnson in January 2023, Alex Gorsky has remained active in the corporate world. He serves as a General Partner at ICONIQ Capital, a technology-focused investment firm. He also sits on the boards of Apple Inc., IBM (as Lead Independent Director), JPMorgan Chase, and Xaira Therapeutics. He continues his philanthropic work through the Travis Manion Foundation and the Wharton School Board of Advisors.
Is Johnson & Johnson a profitable company?
Yes, Johnson & Johnson is highly profitable. In fiscal year 2025, the company reported revenue of $94.2 billion (up 6.0% year-over-year) and net income of $26.8 billion (up over 90% year-over-year). With a market capitalization approaching $600 billion and a consistent dividend history spanning over 60 years, J&J remains one of the most financially robust companies in the world.
Article last updated:February 2026March 2, 2026
Disclaimer: All information presented in this article has been compiled from publicly available sources, including SEC filings, official company press releases, and reputable news outlets. This content is provided for informational purposes only and does not constitute financial or investment advice. Net worth figures are estimates and may vary by source.
Last updated: March 2026